Compare IMU which has 4 clinical trials (3 X phase 1A and 1 X Phase 1B) and CHM (3 X Phase 1B and 1 X Phase 1A) and CHM is massively undervalued.
IMU has an enterprise value of $420m versus CHMs $10m….CHM is crazy good value and I would say the pipeline is superior to IMU. Go figure.
Compare IMU which has 4 clinical trials (3 X phase 1A and 1 X...
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CHM (ASX) Chart |
Day chart unavailable